Brief: Nymox expects submission of initial filing seeking approval for Fexapotide Triflutate in next few weeks
29/03/2017 15:45
March 29 (Reuters) - Nymox Pharmaceutical Corp NYMX.O :
* Nymox provides update on Fexapotide development
* "Now expects to submit its initial filing seeking approval
for Fexapotide Triflutate in next few weeks"
Source text for Eikon: ID:nGNXNSESAa
Further company coverage: NYMX.O
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Nymox Pharmaceutical
See all newsBrief: Nymox Says Required To Resubmit Application To DKMA
Brief: Nymox Pharmaceutical Corp Says Terminated Employment Of Christopher R Riley As CFO (June 27)
Brief: Nymox Announces Appointment Of Christopher R. Riley As Chief Financial Officer
Brief: Nymox Appeals Deficiency Letter
U.S. STOCKS ON THE MOVE-Pot stocks, Nymox, Zynerba